Entrada Therapeutics, Inc.
TRDA
21 insider filings · Latest: Aug 6, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Aug 10, 2026 | Aug 10 11:54 PM | Kush ParmarDirector | Sale | 92,444 | $7.00 | $647.1K | 2,691,337(I) | View → |
| Aug 7, 2026 | Aug 10 11:54 PM | Kush ParmarDirector | Sale | 52,317 | $6.85 | $358.4K | 2,783,781(I) | View → |
| Aug 6, 2026 | Aug 10 11:54 PM | Kush ParmarDirector | Sale | 10,494 | $7.00 | $73.5K | 2,836,098(I) | View → |
| Aug 7, 2026 | Aug 10 11:52 PM | 5AM Ventures V, L.P.10% Owner | Sale | 52,317 | $6.85 | $358.4K | 2,783,781(D) | View → |
| Aug 6, 2026 | Aug 10 11:52 PM | 5AM Ventures V, L.P.10% Owner | Sale | 10,494 | $7.00 | $73.5K | 2,836,098(D) | View → |
| Jul 30, 2026 | Aug 10 11:50 PM | 5AM Ventures V, L.P. | Proposed Sale | 331,156 | $6.55 | $2.2M | — | View → |
| Jul 31, 2026 | Aug 3 9:32 PM | 5AM Ventures V, L.P.10% Owner | Sale | 1,718 | $6.85 | $11.8K | 2,846,592(D) | View → |
| Jul 30, 2026 | Aug 3 9:32 PM | 5AM Ventures V, L.P.10% Owner | Sale | 114,756 | $6.93 | $795.3K | 2,848,310(D) | View → |
| Jul 31, 2026 | Aug 3 9:26 PM | Kush ParmarDirector, 10% Owner | Sale | 1,718 | $6.85 | $11.8K | 2,846,592(I) | View → |
| Jul 30, 2026 | Aug 3 9:26 PM | Kush ParmarDirector, 10% Owner | Sale | 114,756 | $6.93 | $795.3K | 2,848,310(I) | View → |
| Jul 30, 2026 | Jul 30 9:39 PM | 5AM Ventures V, L.P. | Proposed Sale | 331,156 | $6.55 | $2.2M | — | View → |
| May 20, 2026 | May 21 8:31 PM | Bernhardt G ZeiherDirector | Purchase | 5,000 | $5.86 | $29.3K | 5,000(I) | View → |
| May 4, 2026 | May 4 11:25 PM | Natarajan SethuramanPresident, Research & Develop. | Sale | 25,907 | $15.39 | $398.8K | 216,317(D) | View → |
| May 4, 2026 | May 4 11:24 PM | Nathan J DowdenPresident & COO | Sale | 15,000 | $15.33 | $230.0K | 198,588(D) | View → |
| May 4, 2026 | May 4 8:33 PM | NATHAN DOWDEN | Proposed Sale | 15,000 | $14.50 | $217.5K | — | View → |
| May 4, 2026 | May 4 8:32 PM | NATARAJAN SETHURAMAN | Proposed Sale | 25,907 | $14.50 | $375.7K | — | View → |
| Apr 1, 2026 | Apr 2 8:39 PM | Kory James WentworthChief Financial Officer | Sale | 2,500 | $12.95 | $32.4K | 119,010(D) | View → |
| Apr 1, 2026 | Apr 1 8:38 PM | KORY WENTWORTH | Proposed Sale | 2,500 | $12.62 | $31.6K | — | View → |
| Mar 10, 2026 | Mar 11 8:35 PM | Nathan J DowdenPresident & COO | Sale | 11,894 | $13.05 | $155.2K | 198,588(D) | View → |
| Mar 9, 2026 | Mar 11 8:35 PM | Nathan J DowdenPresident & COO | Sale | 3,116 | $13.02 | $40.6K | 210,482(D) | View → |
Page 1 of 3
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jun 10, 2026 | Jun 12 9:34 PM | Kush ParmarDirector, 10% Owner | Grant/Award | 19,000 | $5.97 | 19,000(D) | View → |
| Jun 10, 2026 | Jun 12 9:17 PM | Peter S KimDirector | Grant/Award | 19,000 | $5.97 | 19,000(D) | View → |
| Jun 10, 2026 | Jun 12 9:16 PM | Gina ChapmanDirector | Grant/Award | 19,000 | $5.97 | 19,000(D) | View → |
| Jun 10, 2026 | Jun 12 9:05 PM | Maha RadhakrishnanDirector | Grant/Award | 19,000 | $5.97 | 19,000(D) | View → |
| Jun 10, 2026 | Jun 12 9:01 PM | Mary ThistleDirector | Grant/Award | 19,000 | $5.97 | 19,000(D) | View → |
| Jun 10, 2026 | Jun 12 8:52 PM | Bernhardt G ZeiherDirector | Grant/Award | 19,000 | $5.97 | 19,000(D) | View → |
| May 4, 2026 | May 4 11:24 PM | Nathan J DowdenPresident & COO | Option Exercise | 15,000 | $1.74 | 49,831(D) | View → |
| Mar 1, 2026 | Mar 3 11:21 PM | Dipal DoshiDirector, CEO | Grant/Award | 208,000 | $11.93 | 208,000(D) | View → |
| Mar 1, 2026 | Mar 3 11:20 PM | Kory James WentworthChief Financial Officer | Grant/Award | 66,600 | $11.93 | 66,600(D) | View → |
| Mar 1, 2026 | Mar 3 11:19 PM | Nathan J DowdenPresident & COO | Grant/Award | 83,200 | $11.93 | 83,200(D) | View → |
| Mar 1, 2026 | Mar 3 11:18 PM | Natarajan SethuramanPresident, Research & Develop. | Grant/Award | 83,200 | $11.93 | 83,200(D) | View → |